|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
2
|
Resverlogix Corp.
|
Jun 15, 2018 02:20PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 01:32PM
|
|
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
4
|
Resverlogix Corp.
|
Sep 08, 2021 10:58AM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
5
|
Resverlogix Corp.
|
Aug 30, 2023 08:05PM
|
|
Re: Resverlogix and Zenith Special Meetings
|
5
|
Resverlogix Corp.
|
Jul 01, 2015 10:36AM
|
|
Re: Resverlogix and Zenith Special Meetings
|
4
|
Resverlogix Corp.
|
Jul 01, 2015 11:42AM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
2
|
Resverlogix Corp.
|
Jan 09, 2018 06:31PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
5
|
Resverlogix Corp.
|
Aug 15, 2017 06:26PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
1
|
Resverlogix Corp.
|
Aug 16, 2017 10:58AM
|
|
Re: Resverlogix & Zenith, hmmm...
|
2
|
Resverlogix Corp.
|
May 16, 2015 09:45AM
|
|
Re: Resverlogix & Zenith
|
2
|
Resverlogix Corp.
|
May 15, 2015 05:53PM
|
|
Re: Resverlogix & Zenith
|
3
|
Resverlogix Corp.
|
May 15, 2015 12:14PM
|
|
Re: Response from Sarah -were still a go
|
3
|
Resverlogix Corp.
|
Dec 02, 2021 01:03PM
|
|
Re: Response from Sarah -were still a go
|
5
|
Resverlogix Corp.
|
Dec 02, 2021 05:33PM
|
|
Re: Resolution?
|
1
|
Resverlogix Corp.
|
Oct 03, 2017 09:04AM
|
|
Re: Reports of exempt distribution on SEDAR
|
3
|
Resverlogix Corp.
|
Mar 29, 2018 03:59PM
|
|
Re: Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 24, 2023 10:39AM
|
|
Re: Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Feb 22, 2023 09:43AM
|
|
Re: Reply from Sarah
|
5
|
Zenith Epigenetics
|
Dec 11, 2015 06:20PM
|
|
Re: Reply from Sarah
|
4
|
Zenith Epigenetics
|
Dec 12, 2015 08:56AM
|
